Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$11.05 - $16.62 $1.87 Million - $2.81 Million
-169,200 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$11.69 - $14.54 $1.49 Million - $1.85 Million
-127,400 Reduced 42.95%
169,200 $2.15 Million
Q2 2020

Aug 13, 2020

BUY
$9.75 - $17.6 $2.89 Million - $5.22 Million
296,600 New
296,600 $4.44 Million

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $26.9M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.